Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery

International Journal of Pharmaceutics

Volumn 414, Issue 1-2, 2011, Pages 112-117

  Doan, T V P ^a,b   Couet, W ^a,b,c   Olivier, J C ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Aerosol; Lung delivery; PLGA microspheres; Premix membrane emulsification; Rifampicin; Sustained release

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETIC ACID ETHYL ESTER; KLEPTOSE; MICROSPHERE; POLYGLACTIN; POLYVINYL ALCOHOL; RESOMER; RIFAMPICIN; SOLVENT; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; DRUG DELIVERY SYSTEM; EMULSION; EVAPORATION; FREEZE DRYING; IN VITRO STUDY; PARTICLE SIZE; POROSITY; POWDER; PRESSURE; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION;

ACETATES; AEROSOLS; ANTIBIOTICS, ANTITUBERCULAR; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; LACTIC ACID; LUNG; MEMBRANES, ARTIFICIAL; MICROSPHERES; MODELS, THEORETICAL; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; RIFAMPIN; SOLVENTS;

EID: 79959750261     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.05.007     Document Type: Article

References (24)

1. J.M. Anderson, and M.S. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Deliv. Rev. 28 1997 5 24 (Pubitemid 27497671)
2. Y. Bahl, and H. Sah Dynamic changes in size distribution of emulsion droplets during ethyl acetate-based microencapsulation process AAPS Pharm. Sci. Technol. 1 2000 E5
3. I. Coowanitwong, V. Arya, P. Kulvanich, and G. Hochhaus Slow release formulations of inhaled rifampin AAPS J. 10 2008 342 348
4. P. Costa, and J.M. Sousa Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133 (Pubitemid 32288781)
5. G. Crotte, and T.W. Park Preparation of porous and nonporous biodegradable polymeric hollow microspheres J. Control. Release 35 1995 91 105
6. S. Díez, and C. Tros de Ilarduya Versatility of biodegradable poly(d,l-lactic-co-glycolic acid) microspheres for plasmid DNA delivery Eur. J. Pharm. Biopharm. 63 2006 188 197 (Pubitemid 43776215)
7. T.V.P. Doan, and J.C. Olivier Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization Int. J. Pharm. 382 2009 61 66
8. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M.L. Eskew, J. Mintzes, D. Deaver, N. Lotan, and R. Langer Large porous particles for pulmonary drug delivery Science 276 1997 1868 1871 (Pubitemid 27443665)
9. R. Gurny, E. Doelker, and N.A. Peppas Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers Biomaterials 3 1982 27 32 (Pubitemid 12104449)
10. K. Hirota, T. Hasegawa, T. Nakajima, H. Inagawa, C. Kohchi, G. Soma, K. Makino, and H. Terada Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis J. Control. Release 142 2010 339 346
11. P.P. Le Brun, A.H. de Boer, G.P. Mannes, D.M. de Fraîture, R.W. Brimicombe, D.J. Touw, A.A. Vinks, H.W. Frijlink, and H.G. Heijerman Dry powder inhalation of antibiotics in cystic fibrosis therapy. Part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients Eur. J. Pharm. Biopharm. 54 2002 25 32 (Pubitemid 34663853)
12. M. Li, O. Rouaud, and D. Poncelet Microencapsulation by solvent evaporation: state of the art for process engineering approaches Int. J. Pharm. 363 2008 26 39
13. P. Muttil, C. Wang, and A.J. Hickey Inhaled drug delivery for tuberculosis therapy Pharm. Res. 26 2009 2401 2416
14. H. Sah Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres J. Control. Release 47 1997 233 245 (Pubitemid 27220207)
15. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, D.N. McMurray, and A.J. Hickey Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model Pharm. Res. 18 2001 1315 1319 (Pubitemid 32846326)
16. J.C. Sung, D.J. Padilla, L. Garcia-Contreras, J.L. Verberkmoes, D. Durbin, C.A. Peloquin, K.J. Elbert, A.J. Hickey, and D.A. Edwards Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharm. Res. 26 2009 1847 1855
17. J.C. Sung, B.L. Pulliam, and D.A. Edwards Nanoparticles for drug delivery to the lungs Trends Biotechnol. 25 2007 563 570 (Pubitemid 350138179)
18. F. Tewes, J. Brillault, W. Couet, and J.C. Olivier Formulation of rifampicin-cyclodextrin complexes for lung nebulization J. Control. Release 129 2008 93 99
19. D. Traini, and P.M. Young Delivery of antibiotics to the respiratory tract: an update Expert Opin. Drug Deliv. 6 2009 897 905
20. G.T. Vladisavljević, M. Shimizu, and T. Nakashima Preparation of monodisperse multiple emulsions at high production rates by multi-stage premix membrane emulsification J. Membr. Sci. 244 2004 97 106 (Pubitemid 39440674)
21. G.T. Vladisavljević, and H. Schubert Influence of process parameters on droplet size distribution in SPG membrane emulsification and stability of prepared emulsion droplets J. Membr. Sci. 225 2003 15 23 (Pubitemid 37371922)
22. G.T. Vladisavljević, and R.A. Williams Recent developments in manufacturing emulsions and particulate products using membranes Adv. Colloid Interface Sci. 113 2005 1 20 (Pubitemid 40319840)
23. Q. Wei, W. Wei, R. Tian, L.-y. Wang, Z.-G. Su, and G.-H. Ma Preparation of uniform-sized PELA microspheres with high encapsulation efficiency of antigen by premix membrane emulsification J. Colloid Interface Sci. 323 2008 267 273
24. E.M. Westerman, A.H. de Boer, P.P. Le Brun, D.J. Touw, H.W. Frijlink, and H.G. Heijerman Dry powder inhalation of colistin sulphomethate in healthy volunteers: a pilot study Int. J. Pharm. 335 2007 41 45 (Pubitemid 46482863)